EP Europace · 2012 · 44 citations · 22 references
MedicineCardiologyClinical CardiologyInterventional CardiologyPreventive CardiologyHeart FailureImplantable Cardioverter-defibrillator CareSudden Cardiac Death PreventionImplantable Cardioverter DefibrillatorsInappropriate Shock ReductionLeft Ventricular Ejection Fraction DeclineLeft Ventricular Systolic FunctionLong-term Cardiac Follow-upSudden Death PreventionSystolic DysfunctionVentricular Ejection Fraction Assessment
AIMS: Implantable cardioverter defibrillators (ICDs) are efficient in reducing mortality in patients with left ventricular systolic dysfunction. High-rate cut-off programming may be effective in reducing appropriate and inappropriate therapies, but as the long-term consequences on morbidity and mortality remain unclear, it is underutilized. METHODS AND RESULTS: We prospectively studied 365 consecutive patients (mean age 60 ± 10 years), with ischaemic (63%) or non-ischaemic cardiomyopathy and left ventricular dysfunction (mean ejection fraction 25 ± 7%), who were implanted with an ICD in primary prevention of sudden cardiac death (41% single chamber, 31% dual chamber, and 28% biventricular). All devices were programmed with a shock-only zone over 220 beats per minute (b.p.m.) and a monitoring zone between 170 and 220 b.p.m. During a median follow-up of 40 months, 41 patients received appropriate shocks (11.2%) and 24 inappropriate shocks (6.6%). Then, 306 patients never experienced any ICD shock (84%). Inappropriate discharges were related to supraventricular tachyarrhythmia in 10 patients, and noise/oversensing in 14 patients. Ventricular tachycardia episodes, sustained or not, were recorded in the monitoring zone in 43 patients (11.8%). Seven of these patients were symptomatic (1.9%), without lethal consequence. Sixty-two patients (17%) died: 35 from end-stage heart failure, 1 from unexplained sudden death, and 26 from a documented non-cardiac cause. CONCLUSION: High-rate cut-off (220 b.p.m.) shock-only ICD programming, in primary prevention patients with reduced left ventricular ejection fraction, appeared to be safe during a long-term follow-up. It also resulted in a very low rate of discharges, which are known to be deleterious in this population.
22
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Gust H. Bardy, Kerry L. Lee, Daniel B. Mark et al. · New England Journal of Medicine · 2005 · 6.5K citations · Full text
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
Andrew E. Epstein, John Dimarco, Kenneth A. Ellenbogen et al. · Circulation · 2008 · 1.8K citations · Full text